Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
Date:3/7/2013

operating margin18.7%

18.6%17.9%

20.6%Adjustments:Share-based compensation3,409

3,107

9.7%14,314

11,473

24.8%Amortization of acquired intangible assets408

484

(15.7%)1,983

1,549

28.0%Revaluation of contingent consideration(3,391)

-

NA(3,391)

-

NAImpairment charges for goodwill and intangible assets3,415

-

NA3,415

-

NANon-GAAP operating income27,398

23,803

15.1%105,740

96,832

9.2%Non-GAAP operating margin21.8%

21.9%21.2%

23.8%GAAP net income23,821

23,481

1.4%86,584

80,979

6.9%GAAP net margin19.0%

21.6%17.3%

19.9%Adjustments:Share-based compensation3,409

3,107

9.7%14,314

11,473

24.8%Amortization of acquired intangible assets408

484

(15.7%)1,983

1,549

28.0%Deferred tax impact related to acquired intangible assets(150)

(137)

9.5%(734)

(591)

24.2%Revaluation of contingent consideration(3,391)

-

NA(3,391)

-

NAImpairment charges for goodwill and intangible assets3,415

-

NA3,415

-

NANon-GAAP net income27,512

26,935

2.1%102,171

93,410

9.4%Non-GAAP net margin21.9%

24.8%20.4%

22.9%GAAP net income23,821

23,481

1.4%86,584

80,979

6.9%Add back:Depreciation and amortization11,468

9,361

22.5%41,672

33,997

22.6%Interest (income) expenses, net(1,487)

(1,819)

(18.3%)(6,010)

(5,266)

14.1%Income tax expenses (benefit)4,508

3,917

15.1%17,393

16,606

4.7%EBITDA38,310

34,940

9.6%139,639

126,316

10.5%Adjustments:Sh
'/>"/>

SOURCE Wuxi PharmaTech Co. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
2. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
3. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
4. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
5. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
6. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
7. WuXi PharmaTech to Manufacture Ibalizumab for TaiMed Biologics
8. WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
11. WuXi PharmaTech Announces First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... Der Pharmariese Lupin ... eine 100-prozentige Beteiligung am Unternehmen ZAO "Biocom" ... Übernahme dringt Lupin in den russischen Pharmamarkt ... Mrd. RUB im Jahr 2014 zu den ... Health). Seit über einem Jahrzehnt verzeichnet der ...
(Date:7/2/2015)... , July 3, 2015 ... adquisición del 100% de participación en ZAO "Biocom" ... adquisición marca la incursión de Lupin en el ... de RUB en ventas, colocándolo como uno de ... 2014 (IMS Health). Durante más de una década, ...
(Date:7/2/2015)... , July 2, 2015 /PRNewswire/ - ESSA Pharma Inc. ... common shares have been approved for listing and trading on ... ESSA will begin trading on NASDAQ on July 9, ... Venture Exchange under the symbol "EPI". As a ... NASDAQ, each of the Company,s outstanding special warrants issued on ...
Breaking Medicine Technology:Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4
... Saudi Arabia, Nov. 2, 2010 The Saudi Arabian ... has signed an agreement with Varian Medical Systems and ... magnetic resonance-guided radiation therapy (MRgRT™). Under the ... solution that combines IMRIS, unique movable magnetic resonance imaging ...
... Quarter 2010 Results and Host Conference... -- POINT RICHMOND, Calif., Nov. 2, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results ...
Cached Medicine Technology:Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 2Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 3Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 4Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 2Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 3Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 4Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 5Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 6Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 7Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 8Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 9
(Date:7/3/2015)... ... 2015 , ... The Erie County Bar Association Institute of ... Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... these types of cases. , Each year, New York State residents are hospitalized ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ... the latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert ... selfie sticks are great for documenting memories. , Almost every smartphone has an incredibly ...
(Date:7/2/2015)... ... ... pleased to announce the opening of its newest location in Dallas, Texas. The opening is ... chain was listed as #22 on the Inc. 500 list of fastest growing companies in ... located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 , “We are excited ...
(Date:7/2/2015)... ... , ... Many Fourth of July celebrations will include fireworks this summer, so ... sharing some tips to promote the proper use of fireworks. , According to the ... daily with fireworks-related injuries in the month surrounding the Fourth of July. Amica is ...
(Date:7/2/2015)... CITY, GA (PRWEB) , ... July 02, 2015 ... ... field sporting the newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the socks ... fitness experts and athletic trainers. Their significant popularity has inspired four new, fun ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2
... supply for the ... healthcare industry, OTTAWA, Oct. ... radiopharmaceuticals, signed a 17-year,contract for the supply of cobalt-60 with Rosenergoatom, ... the,2005 agreement by providing for an increased supply of cobalt-60 to ...
... New Non-Steroidal Skin Treatment to Treat All ... with Steroids, BARRINGTON, Ill., Oct. 19 Steroids have ... abuse. There must be reasons why,people use steroid products on ... largest organ of the human body, and it needs to ...
... 19 VioQuest,Pharmaceuticals (OTC Bulletin Board: VQPH), ... developing and,commercializing targeted cancer therapeutics, announced today ... presentations pertaining to VQD-002 (TCN-PM),and Lenocta(TM) (SSG) ... Conference sponsored by the American Association for ...
... per month, experts say , FRIDAY, Oct. 19 (HealthDay News) ... severe kidney disease could help improve patients, quality of life, ... giving patients an anti-anemia drug as infrequently as once a ... the Renal Research Institute in New York, and colleagues. , ...
... Earnings Per Share Exceeds Guidance -, EXTON, Pa., Oct. ... the results for its first quarter of fiscal,year 2008. ... which include net sales,and royalty income, were $17.6 million in ... $16.3 million in the prior year first quarter. Net ...
... Israel, October 19 Healthcare,Technologies Ltd. (NASDAQ: HCTL ... shareholders, previously scheduled for September 30,2007, will be held ... offices of,Yigal Arnon & Co., 1 Azrieli Center, Round ... shareholders will be asked to approve the previously,announced Asset ...
Cached Medicine News:Health News:MDS Nordion signs 17-year contract with Rosenergoatom 2Health News:Steroids Are Abused for Skin, Not Just Muscles 2Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 2Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 3Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 4Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 5Health News:Simpler Anemia Treatment May Help Kidney Patients 2Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 2Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 3Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 4Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 5Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 6Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 7Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 8Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 9Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 10Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 11Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 12Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 13Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 14Health News:Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction 2Health News:Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction 3
Steroid-eluting, screw-in pacing lead...
... Tendril SDX is one ... pacing leads. Implantable with a ... reduced body diameter is designed ... venous obstruction and allow introduction ...
... Tendril SDX is one of ... leads. Implantable with a 7 ... body diameter is designed to ... obstruction and allow introduction in ...
... Crystalline Active fixation lead series are ... extendable retractable helix mechanism, specifically designed ... pacemaker system, reducing the sensing of ... Crystalline Active fixation leads allow a ...
Medicine Products: